Skip to main navigation Skip to search Skip to main content

Rationale for effective interventions to mitigate oral mucositis in patients being treated with TROP-2-directed antibody-drug conjugates with a topoisomerase inhibitor payload

  • Stephen Thomas Sonis
  • , Paolo Bossi
  • , Hannah Rose Wardill
  • , Aaron Lisberg
  • , Nathaniel Simon Treister
  • , Alessandro Villa

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Article number100784
JournalOral Oncology Reports
Volume18
DOIs
StatePublished - Jun 2026

ASJC Scopus Subject Areas

  • Oncology

Keywords

  • Antibody-drug conjugates
  • Cancer chemotherapy
  • mTOR inhibitors
  • Oral mucositis
  • Topoisomerase inhibitor
  • TROP-2

Cite this